Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction | Zendy

Simon Greulich | Zendy; Daniel Kitterer | Zendy; Joerg Latus | Zendy; Eissa N. E. Aguor | Zendy; Hannah Steubing | Zendy; Philipp Kaesemann | Zendy; Alexandru Patrascu | Zendy; Andreas Greiser | Zendy; Stefan Groeninger | Zendy; Agnes Mayr | Zendy; Niko Braun | Zendy; Mark Dominik Alscher | Zendy; Udo Sechtem | Zendy; Heiko Mahrholdt | Zendy

Open Access

Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction

Author(s) -

Simon Greulich,

Daniel Kitterer,

Joerg Latus,

Eissa N. E. Aguor,

Hannah Steubing,

Philipp Kaesemann,

Alexandru Patrascu,

Andreas Greiser,

Stefan Groeninger,

Agnes Mayr,

Niko Braun,

Mark Dominik Alscher,

Udo Sechtem,

Heiko Mahrholdt

Publication year - 2016

Publication title -

circulation cardiovascular imaging

Language(s) - English

Resource type - Journals

eISSN - 1942-0080

pISSN - 1941-9651

DOI - 10.1161/circimaging.116.005022

Subject(s) - ejection fraction , cardiology , magnetic resonance imaging , medicine , cardiac magnetic resonance , cardiac sarcoidosis , sarcoidosis , radiology , heart failure

Cardiac sarcoidosis (CS) may manifest as arrhythmia or even sudden cardiac death. Because patients with CS often present with nonspecific symptoms, normal electrocardiography, and preserved left ventricular ejection fraction, a reliable diagnostic tool for the work-up of CS is needed. Late gadolinium enhancement-cardiovascular magnetic resonance has proven diagnostic value in CS but has some limitations that may be overcome by adding newer cardiovascular magnetic resonance mapping techniques. The aim of our study was to evaluate a comprehensive cardiovascular magnetic resonance protocol, including late gadolinium enhancement and mapping sequences in sarcoid patients with no symptoms or unspecific symptoms and preserved left ventricular ejection fraction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research